Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-free DNA (cfDNA) refers to extracellular fragments of DNA that are freely circulating in various body fluids. These fragments are typically double-stranded and range in size from about 120 to 220 base pairs. cfDNA can originate from both normal cellular processes and pathological conditions. It serves as an important biomarker for multiple clinical applications, including cancer diagnostics, prenatal testing, and transplantation monitoring.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-free DNA (cfDNA).